Combining genomic analyses with information about clinical outcomes is a highly promising strategy to understanding prostate cancer and its treatment. Researchers say it could change how the disease is predicted and make treatment timelier and more personalized.
Combining genomic analyses and outcome data is promising strategy for prostate cancer treatment retrieved 26 June 2024 from https://medicalxpress.com/news/2024-06-combining-genomic-analyses-outcome-strategy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jun 20, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Combining biomedical data from breast cancer patients could lead to 'groundbreaking discoveries'Studying combined data from the UK Biobank, a unique record of patient information from more than half a million Britons, could help make 'groundbreaking discoveries' in the understanding and treatment of breast cancer, say researchers.
Read more »
Combining donepezil and memantine extends lives of Alzheimer's patients, study findsAlzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally.
Read more »
Six distinct types of depression identified in study combining brain imaging with machine learningIn the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.
Read more »
Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy responseBecause not all cancer patients respond to a leading type of cancer immunotherapy drug, known as an immune checkpoint inhibitor, scientists explored whether adding janus kinase (JAK) inhibitors – drugs that treat chronic inflammation – could help.
Read more »
Researchers develop new compound designed to treat drug-resistant acute myeloid leukemiaResearchers at Purdue University's College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
Read more »
Researchers develop 3D model to better treat neurological disordersA 3D model developed by West Virginia University neuroscientists shows how implantable stimulators—the kind used to treat chronic pain—can target neurons that control specific muscles to provide rehabilitation for people with neurological disorders such as stroke and spinal cord injuries.
Read more »